Russia Registers New Locally Developed Smallpox Drug Neokh-14
Russia has officially registered a new locally developed drug against smallpox, named Neokh-14, according to Anna Popova, head of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor).
Popova stated that the drug is effective in treating infections caused by the smallpox virus, as well as monkeypox and cowpox. She added that Neokh-14 was developed at the State Research Centre of Virology and Biotechnology 'Vector', which operates under the Russian Federal Service for Surveillance on Consumer Rights Protection.
Smallpox is a contagious viral disease that the World Health Organization declared eradicated in 1980. However, concerns about its spread have resurfaced in recent years following monkeypox outbreaks in several countries.
In response, Russia has intensified efforts to develop new drugs and vaccines to counter any potential spread of the virus.